Award details

Re-targeting adenoviruses to the vascular endothelium for safe and effective gene therapy of diverse pathologies

ReferenceGTH12582
Principal Investigator / Supervisor Professor Andrew Baker
Co-Investigators /
Co-Supervisors
Professor Dame Anna Dominiczak, Professor Robert Hawkins, Professor Gordon Jayson, Dr Sarah Watkins
Institution University of Glasgow
DepartmentInst of Cardiovascular &Medical Sci
Funding typeResearch
Value (£) 331,314
StatusCompleted
TypeResearch Grant
Start date 17/01/2000
End date 31/10/2003
Duration45 months

Abstract

The development of an efficient gene targeting system for the vascular endothelium is a pre- requisite for gene therapy to be fully exploited in diverse clinical situations. We have previously developed an endothelial cell-specific gene delivery system by incorporating novel targeting peptides and cell-specific promoters into adenoviral vectors. We wish to optimise gene delivery in vitro and in vivo and compare this for efficacy and persistence of gene expression to non-targeted adenoviral vectors. Using model therapies, the effect of overexpression of vasodilator genes from the endothelium in hypersensitive rats and the effect of overexpression of cytotoxin genes in the angiogenic endothelium of cancer will be evaluated.

Summary

unavailable
Committee Closed Committee - Genes & Developmental Biology (GDB)
Research TopicsX – not assigned to a current Research Topic
Research PriorityX – Research Priority information not available
Research Initiative Gene Technologies Underpinning Healthcare (GTH) [1999]
Funding SchemeX – not Funded via a specific Funding Scheme
terms and conditions of use (opens in new window)
export PDF file